Doctors attempt First-Ever cure in the womb for devastating genetic disease
NCT ID NCT07408583
Summary
This early-stage study is testing whether a stem cell transplant given to a fetus still in the womb is safe and can treat Fanconi anemia, a severe genetic disease. Doctors will collect stem cells from the mother and infuse them into the fetus, hoping to correct the blood disorder before birth. The goal is to prevent the need for a risky bone marrow transplant later in childhood or to make a future transplant safer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC DISEASES, INBORN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
Stanford, California, 94305, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.